• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,569.39 827.57
( 1.08%)
Global Indices
Nasdaq
52,499.17 129.78
(0.25%)
Dow Jones
7,562.80 59.09
(0.79%)
Hang Seng
68,634.11 890.26
(1.31%)
Nikkei 225
10,472.08 -16.96
(-0.16%)
Forex
USD-INR
95.15 -0.21
(-0.22%)
EUR-INR
108.73 -0.26
(-0.24%)
GBP-INR
127.27 -0.11
(-0.09%)
JPY-INR
0.59 0.00
(-0.14%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
132.2958859
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
45.59
41387.59
EPS(TTM)
Face Value()
Div & Yield %
53.59
10
2.33
 

As on: Jul 10, 2026 12:00 AM

Last Price() Net Change (%) Volume (Nos) P / E
2,435.50 -7.60 2897 45.59
Stock Price Details
Open Price() 2,434.40
Best Buy () 0
Best Sell () 0
Buy Quantity (Nos) 0
Sell Quantity (Nos) 0
Today's High () 2,454.00
Today's Low () 2,422.55
52-Week High () 3343.05
152-Week Low () 2088
CHART
  • |
  • |
  • |
  • |
Market Statistics
Div & Yield % 2.33
Eps 53.59
Book Value 132.2958859
Market Cap (.Cr) 41,387.59
Face Value 10
Market Lot 1
AGM Date Jun
Book Closure Date
ISIN No. INE159A01016


News
Volumes soar at Glaxosmithkline Pharmaceuticals Ltd counter
GSK Pharma gains as Q4 PAT rises 6% YoY to Rs 275 cr
GlaxoSmithKline Pharmaceuticals to hold AGM
Board of GlaxoSmithKline Pharmaceuticals recommends Final Dividend
Glaxosmithkline Pharmaceuticals consolidated net profit rises 5.70% in the March 2026 quarter
GSK Pharma Q4 PAT rises 6% YoY to Rs 275 cr
GlaxoSmithKline Pharmaceuticals to announce Quarterly Result
Glaxosmithkline appoints Vinay Subramanian as Commercial Head – Oncology
Glaxosmithkline Pharmaceuticals consolidated net profit rises 28.60% in the December 2025 quarter
More
Corporate Details
Incoporation Year   : 1924
Chairman : Renu S. Karnad
Bussiness Group : MNC Asc-Glaxo
Registered Office
Glaxosmithkline Pharmaceuticals Ltd
GSK House,
Dr Annie Besant Road Worli,
Mumbai,
Maharashtra-400030
Cement House,
121 Maharshi Karve Road,
Mumbai,
Maharashtra-400020
Phone:91-022-24959595
Fax:91-022-24959494
Fax:91-22-66317458
E-Mail : askus@gsk.com; ajay.a.nadkarni@gsk.com
URL : http://www.gsk-india.com


Exchange Information
Bombay Stock Exchange National Stock Exchange Other Listed Exchanges
  • BSE 500
  • BSE 200
  • BSE HC
  • BSE DOLLEX
  • BSE Midcap
  • CNX 500
  • BSE
  • Kolkata
  • Chennai
  • Ahmedabad
  • Delhi
  • Kochi